Korea Pharma Co (XKRX:032300) Total Assets : ₩121,128 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Total Assets?

Korea Pharma Co's Total Assets for the quarter that ended in Mar. 2024 was ₩121,128 Mil.

During the past 12 months, Korea Pharma Co's average Total Assets Growth Rate was 1.80% per year. During the past 3 years, the average Total Assets Growth Rate was 5.30% per year. During the past 5 years, the average Total Assets Growth Rate was 6.10% per year.

During the past 8 years, Korea Pharma Co's highest 3-Year average Total Assets Growth Rate was 8.40%. The lowest was 5.30%. And the median was 6.90%.

Total Assets is connected with ROA %. Korea Pharma Co's annualized ROA % for the quarter that ended in Mar. 2024 was 4.34%. Total Assets is also linked to Revenue through Asset Turnover. Korea Pharma Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.17.

Korea Pharma Co Total Assets Historical Data

The historical data trend for Korea Pharma Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Total Assets Chart

Korea Pharma Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

66,747.38

81,320.13

129,401.35

130,947.16

121,303.37

Korea Pharma Co Quarterly Data
	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															131,874.99	132,690.62	135,075.90	121,303.37	121,128.30

Korea Pharma Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Korea Pharma Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	68581.531	+	52721.842
	=	121,303

Korea Pharma Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	69352.866	+	51775.434
	=	121,128

Korea Pharma Co (XKRX:032300) Total Assets Explanation

Total Assets is connected with ROA %.

Korea Pharma Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	5266.68	/	( (121303.373	+	121128.299)	/ 2 )
	=	5266.68	/	121215.836
	=	4.34 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Korea Pharma Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	20280.722	/	( (121303.373	+	121128.299)	/ 2 )
=	20280.722	/	121215.836
=	0.17

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Korea Pharma Co Total Assets Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Pharma Co (XKRX:032300) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR

Website

http://www.koreapharma.co.kr

Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co (XKRX:032300) Headlines

No Headlines